Earnings History Data for Avidity Biosciences (RNA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Avidity Biosciences

Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		RNA	Avidity Biosciences	4,951	-0.65	-0.79	0.00	Avidity Biosciences reports Q3 results [11/8/2024 12:12 AM]	46.78	-0.73 (-1.54%)	48.50	0.99 (2.08%)	5.15 - 50.78	844,023	850,000	773
Avidity Biosciences reports Q3 results [11/8/2024 12:12 AM]
09-08-2024	AH		RNA	Avidity Biosciences	3,932	-0.65	-0.76	0.00	Avidity Biosciences GAAP EPS of -$0.65 beats by $0.14, revenue of $2.05M misses by $0.96M [8/9/2024 4:16 PM]	44.40	-2.55 (-5.43%)	46.50	-0.45 (-0.96%)	4.82 - 48.80	1,102,653	1,150,000	1,343

09-05-2024	AH		RNA	Avidity Biosciences	2,428	-0.79	-0.81	0.00	Avidity Biosciences GAAP EPS of -$0.79 beats by $0.07, revenue of $3.54M beats by $0.97M [5/9/2024 5:46 PM]	25.89	-1.21 (-4.46%)	26.50	-0.60 (-2.21%)	4.82 - 27.66	999,359	850,000	1,610
Avidity Biosciences GAAP EPS of -$0.79 beats by $0.07, revenue of $3.54M beats by $0.97M [5/9/2024 5:46 PM] Avidity Biosciences files automatic mixed shelf [5/9/2024 4:43 PM]
08-11-2023	AH		RNA	Avidity Biosciences	393.00	-0.71	-0.76	0.00	Avidity Biosciences GAAP EPS of -$0.71 beats by $0.05, revenue of $2.8M beats by $0.96M [11/8/2023 5:48 PM]	5.49	0.07 (1.20%)	5.70	0.28 (5.17%)	4.82 - 25.74	697,892	680,000	1,380
Avidity Biosciences GAAP EPS of -$0.71 beats by $0.05, revenue of $2.8M beats by $0.96M [11/8/2023 5:48 PM]
28-02-2023	AH		RNA	Avidity Biosciences	1,240	-0.88	-0.84	0.00	Avidity Biosciences GAAP EPS of -$88.00 misses by $87.11, revenue of $2.77M beats by $0.89M [2/28/2023 5:41 PM]	24.36	0.66 (2.78%)	25.31	1.61 (6.79%)	9.83 - 25.74	541,976	800,000	1,233
Avidity Biosciences GAAP EPS of -$0.88, revenue of $2.77M beats by $0.89M [2/28/2023 5:41 PM]
10-05-2022	AH	4:05 PM ET (May 10)	RNA	Avidity Biosciences, Inc.	614.08	-0.71	-0.94	-0.64	Avidity Biosciences GAAP EPS of -$0.71 beats by $0.09, revenue of $1.8M misses by $0.1M [5/10/2022 5:48 PM]	11.13	-1.07 (-8.77%)	12.20	0.0 (0.00%)	11.08 - 29.59	288,621	260,000	332
Avidity Biosciences GAAP EPS of -$0.71 beats by $0.09, revenue of $1.8M misses by $0.1M [5/10/2022 5:48 PM] Avidity Biosciences, Inc. (RNA) Reports Q1 Loss, Tops Revenue Estimates [May-10-22 06:15PM] Avidity Biosciences Reports First Quarter 2022 Financial Results and Recent Highlights [May-10-22 04:05PM]
01-03-2022	AH	4:05 PM ET (Mar 1)	RNA	Avidity Biosciences	767.00	-0.82	-0.73	0.00	Avidity Biosciences GAAP EPS of -$0.82, revenue of $1.85M [3/1/2022 4:58 PM]	17.07	0.73 (4.43%)	16.35	0.0 (0.00%)	13.39 - 29.59	149,408	440,000	4,957
Avidity Biosciences GAAP EPS of -$0.82, revenue of $1.85M [3/1/2022 4:58 PM] Avidity Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Highlights [Mar-01-22 04:05PM] Avidity Biosciences Honors Rare Disease Day® [Feb-28-22 09:00AM] Reata Pharmaceuticals, Inc. (RETA) Reports Q4 Loss, Lags Revenue Estimates [Feb-28-22 08:05AM] Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Lags Revenue Estimates [Mar-01-22 05:55PM]
12-05-2021	AH	4:05 PM ET (May 12)	RNA	Avidity Biosciences, Inc.	814.00	-0.64	-0.52	0.00	Avidity Biosciences EPS misses by $0.09, beats on revenue [5/12/2021 4:49 PM]	19.60	-3.70 (-15.88%)	23.30	0.0 (0.00%)	19.12 - 37.46	373,600	210,000	4,227
Avidity Biosciences EPS misses by $0.09, beats on revenue [5/12/2021 4:49 PM] Avidity Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights [May-12-21 04:05PM] Lilly, MiNA Ink Broad RNA Deal Worth $1.25B [May-11-21 09:39AM]
15-03-2021	AH		RNA	Avidity Biosciences, Inc.	962.18	-0.43	0.00	0.00	Avidity Biosciences EPS misses by $0.10, beats on revenue [3/15/2021 4:29 PM]	27.54	1.01 (3.81%)	26.80	0.27 (1.02%)	21.34 - 37.46	403,481	391,610	202
Avidity Biosciences EPS misses by $0.10, beats on revenue [3/15/2021 4:29 PM] Avidity Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Highlights [Mar-15-21 04:05PM] We Think Avidity Biosciences (NASDAQ:RNA) Can Afford To Drive Business Growth [Mar-15-21 07:40AM]